Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports

• Secondary uterine sarcomas occur in < 1% of patients treated with CCRT. • Secondary uterine sarcomas can occur > 5 years from CCRT. • The median survival period from the secondary tumor occurrence was only 4 months. • All our patients had heterologous carcinosarcoma of the uterine corpus....

Descripción completa

Detalles Bibliográficos
Autores principales: Wakayama, Akihiko, Kudaka, Wataru, Nakasone, Tadaharu, Taira, Yusuke, Aoki, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524167/
https://www.ncbi.nlm.nih.gov/pubmed/28761924
http://dx.doi.org/10.1016/j.gore.2017.07.008
_version_ 1783252427487576064
author Wakayama, Akihiko
Kudaka, Wataru
Nakasone, Tadaharu
Taira, Yusuke
Aoki, Yoichi
author_facet Wakayama, Akihiko
Kudaka, Wataru
Nakasone, Tadaharu
Taira, Yusuke
Aoki, Yoichi
author_sort Wakayama, Akihiko
collection PubMed
description • Secondary uterine sarcomas occur in < 1% of patients treated with CCRT. • Secondary uterine sarcomas can occur > 5 years from CCRT. • The median survival period from the secondary tumor occurrence was only 4 months. • All our patients had heterologous carcinosarcoma of the uterine corpus.
format Online
Article
Text
id pubmed-5524167
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-55241672017-07-31 Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports Wakayama, Akihiko Kudaka, Wataru Nakasone, Tadaharu Taira, Yusuke Aoki, Yoichi Gynecol Oncol Rep Case Report • Secondary uterine sarcomas occur in < 1% of patients treated with CCRT. • Secondary uterine sarcomas can occur > 5 years from CCRT. • The median survival period from the secondary tumor occurrence was only 4 months. • All our patients had heterologous carcinosarcoma of the uterine corpus. Elsevier 2017-07-17 /pmc/articles/PMC5524167/ /pubmed/28761924 http://dx.doi.org/10.1016/j.gore.2017.07.008 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Wakayama, Akihiko
Kudaka, Wataru
Nakasone, Tadaharu
Taira, Yusuke
Aoki, Yoichi
Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
title Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
title_full Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
title_fullStr Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
title_full_unstemmed Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
title_short Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
title_sort secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524167/
https://www.ncbi.nlm.nih.gov/pubmed/28761924
http://dx.doi.org/10.1016/j.gore.2017.07.008
work_keys_str_mv AT wakayamaakihiko secondaryuterinecarcinosarcomaafterconcurrentchemoradiotherapyforcervicalcancercasereports
AT kudakawataru secondaryuterinecarcinosarcomaafterconcurrentchemoradiotherapyforcervicalcancercasereports
AT nakasonetadaharu secondaryuterinecarcinosarcomaafterconcurrentchemoradiotherapyforcervicalcancercasereports
AT tairayusuke secondaryuterinecarcinosarcomaafterconcurrentchemoradiotherapyforcervicalcancercasereports
AT aokiyoichi secondaryuterinecarcinosarcomaafterconcurrentchemoradiotherapyforcervicalcancercasereports

Ejemplares similares